Your browser doesn't support javascript.
loading
The origins and potential future of SARS-CoV-2 variants of concern in the evolving COVID-19 pandemic.
Otto, Sarah P; Day, Troy; Arino, Julien; Colijn, Caroline; Dushoff, Jonathan; Li, Michael; Mechai, Samir; Van Domselaar, Gary; Wu, Jianhong; Earn, David J D; Ogden, Nicholas H.
Afiliación
  • Otto SP; Department of Zoology and Biodiversity Research Centre, University of British Columbia, Vancouver, BC V6T 1Z4, Canada. Electronic address: otto@zoology.ubc.ca.
  • Day T; Department of Mathematics and Statistics, Department of Biology, Queen's University, Kingston, ON K7L 3N6, Canada.
  • Arino J; Department of Mathematics and Data Science Nexus, University of Manitoba, Winnipeg, MB R3T 2N2, Canada.
  • Colijn C; Department of Mathematics, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
  • Dushoff J; Department of Biology and M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4L8, Canada.
  • Li M; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, Guelph, ON N1G 3W4, Canada.
  • Mechai S; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, St. Hyacinthe, QC J2S 2M2, Canada.
  • Van Domselaar G; National Microbiology Laboratory - Public Health Agency of Canada, Winnipeg, MB R3E 3R2, Canada; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg, MB R3E 0J9, Canada.
  • Wu J; Laboratory for Industrial and Applied Mathematics, York University, Toronto, ON M3J 1P3, Canada.
  • Earn DJD; Department of Mathematics and Statistics and M.G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4K1, Canada.
  • Ogden NH; Public Health Risk Sciences Division, National Microbiology Laboratory, Public Health Agency of Canada, St. Hyacinthe, QC J2S 2M2, Canada.
Curr Biol ; 31(14): R918-R929, 2021 07 26.
Article en En | MEDLINE | ID: mdl-34314723
One year into the global COVID-19 pandemic, the focus of attention has shifted to the emergence and spread of SARS-CoV-2 variants of concern (VOCs). After nearly a year of the pandemic with little evolutionary change affecting human health, several variants have now been shown to have substantial detrimental effects on transmission and severity of the virus. Public health officials, medical practitioners, scientists, and the broader community have since been scrambling to understand what these variants mean for diagnosis, treatment, and the control of the pandemic through nonpharmaceutical interventions and vaccines. Here we explore the evolutionary processes that are involved in the emergence of new variants, what we can expect in terms of the future emergence of VOCs, and what we can do to minimise their impact.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Curr Biol Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 Límite: Animals / Humans Idioma: En Revista: Curr Biol Asunto de la revista: BIOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Reino Unido